In the time-independent study, increased expression levels of suppressor PD-L1 marker on tumour-associated myeloid-derived suppressor cells (MDSCs; CD11b+Ly-6G+Ly-6C−) was observed only in nsECT4-treated compared to untreated and μsECT-treated mice (Figure 6E). Here, CD274 is linked to neoplasm.